Autori: Zielinski Christoph
| Naslov | HERIZON: A phase II study of HER-Vaxx (IMU-131), a HER2targeting peptide vaccine plus standard of care chemotherapy in patients with HER2+advanced stomach cancer - Dose-dependent anti-cancer antibodies correlating with improved clinical outcome (Meeting Abstract) |
| Autori | Tobias Joshua Kundi Michael Garner-Spitzer E Zielinski Christoph Maglakelidze Marina Andric Zoran G Petrovic Z Nagarkar R Chawla T Chong LO Nixon B Yavrom S Ede NJ Wiedermann Ursula |
| Info | ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 2, str. S864-S864 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2t-argeting peptide vaccine plus SOC chemotherapy in patients with HER2+advanced stomach cancer - correlation of the antibody responses and clinical outcome (Meeting Abstract) |
| Autori | Tobias Joshua Kundi Michael Garner-Spitzer E Zielinski Christoph Maglakelidze Marina Andric Zoran G Petrovic Zeljko M Nagarkar R Chawla T Chong LMO Nixon B Yavrom S Ede NJ Wiedermann Ursula |
| Info | ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 1, str. S4-S4 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis (Article) |
| Autori | Cufer Tanja Ciuleanu Tudor E Berzinec Peter Galffy Gabriela Jakopovic Marko Jassem Jacek Jovanovic Dragana D Mihaylova Zhasmina Ostoros Gyula Thallinger Christiane Zemanova Milada Zielinski Christoph |
| Info | ONCOLOGIST, (2020), vol. 25 br. 3, str. E598-E601 |
| Projekat | AstraZeneca |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries (Review) |
| Autori | Wilking Nils Bucsics Anna Kandolf-Sekulovic Lidija O Kobelt Gisela Laslop Andrea Makaroff Lydia Roediger Alexander Zielinski Christoph |
| Info | ESMO OPEN, (2019), vol. 4 br. 6, str. - |
| Projekat | Central European Cooperative Group (CECOG); Merck Sharp DohmeMerck & Company; Boehringer Ingelheim |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries (Review) |
| Autori | Wilking Nils Bucsics Anna Kandolf-Sekulovic Lidija O Kobelt Gisela Laslop Andrea Makaroff Lydia Roediger Alexander Zielinski Christoph |
| Info | ESMO OPEN, (2019), vol. 4 br. 6, str. - |
| Projekat | Central European Cooperative Group (CECOG) by Merck Sharp Dohme; Central European Cooperative Group (CECOG) by Boehringer Ingelheim |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group (Article) |
| Autori | Ryska Ales Buiga Rares Fakirova Albena Kern Izidor Olszewski Wlodzimierz Plank Lukas Seiwerth Sven Toth Erika Eri Zivka Thallinger Christiane Zielinski Christoph Brcic Luka |
| Info | ONCOLOGIST, (2018), vol. 23 br. 12, str. E152-E158 |
| Projekat | Ministry of Education, Youth and Sports, Czech Republic [CZ.02.1.01/0.0/0.0/16_013/0001674]; AstraZeneca |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study (Article) |
| Autori | Brodowicz Thomas Ciuleanu Tudor E Radosavljevic Davorin Z Shacham-Shmueli Einat Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank M Purkalne Gunta Messinger D Zielinski Christoph |
| Info | ANNALS OF ONCOLOGY, (2013), vol. 24 br. 7, str. 1769-1777 |
| Projekat | CECOG |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) (Meeting Abstract) |
| Autori | Ciuleanu Tudor E Nikolic Vladimir Shmueli E Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank M Purkalne Gunta Brodowicz Thomas Zielinski Christoph |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 15, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC). (Meeting Abstract) |
| Autori | Ciuleanu Tudor E Nikolic Vladimir Shmueli E Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank Magdolna Purkalne Gunta Brodowicz Thomas Zielinski Christoph |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 4, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Cetuximab Weekly (Q1W) Versus Every Two Weeks (Q2W) Plus Folfox4 as First-line Therapy in Patients (PTS) with Kras Wild-Type (WT) Metastatic Colorectal Cancer (MCRC) (Meeting Abstract) |
| Autori | Ciuleanu Tudor E Nikolic Vladimir Shacham-Shmueli Einat Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Kahan Zsuzsanna Purkalne Gunta Brodowicz Thomas Zielinski Christoph |
| Info | ANNALS OF ONCOLOGY, (2011), vol. 22 br. , Suppl. Suppl. 5, str. v22-v22 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
